SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
30-Sep-24 7:11 PM View: | Onconetix, Inc. (ONCO) | 26-Sep-24 | Grant | 3,318 | -- | -- | 2087% 0.16K to 3.48K | |
03-Jul-24 2:33 PM View: | Entero Therapeutics, Inc. (ENTO) | 02-Jul-24 | Sale | 1,289 | $1.07 | $1,379.23 | (3%) 37.1K to 35.82K | |
03-Apr-24 5:14 PM View: | Entero Therapeutics, Inc. (ENTO) | 01-Apr-24 | Private Sale | 174 | $4.23 | $735.92 | (< 1%) 37.28K to 37.1K | |
19-Mar-24 4:13 PM View: | Entero Therapeutics, Inc. (ENTO) | 15-Mar-24 | Private Sale | 1,887 | $4.96 | $9,359.52 | (5%) 39.17K to 37.28K | |
17-Jan-24 4:01 PM View: | Entero Therapeutics, Inc. (ENTO) | 12-Jan-24 | Private Sale | 166 | $4.20 | $697.20 | (< 1%) 39.33K to 39.17K | |
03-Jan-24 7:55 PM View: | Entero Therapeutics, Inc. (ENTO) | 02-Jan-24 | Grant | 20,000 | -- | -- | 103% 19.33K to 39.33K | |
03-Jan-24 7:55 PM View: | Entero Therapeutics, Inc. (ENTO) | 29-Dec-23 | Grant | 17,660 | -- | -- | 1056% 1.67K to 19.33K | |
06-Oct-23 4:04 PM View: | Entero Therapeutics, Inc. (ENTO) | 04-Oct-23 | Sale | 2,764 | $0.29 | $801.56 | (8%) 36.16K to 33.4K | |
05-Jul-23 4:27 PM View: | Entero Therapeutics, Inc. (ENTO) | 03-Jul-23 | Sale | 3,349 | $1.54 | $5,157.46 | (8%) 39.51K to 36.16K | |
01-Jun-23 9:10 PM View: | Onconetix, Inc. (ONCO) | 31-May-23 | Grant | 6,360 | -- | -- | 100% 0 to 6.36K | |
05-Apr-23 4:07 PM View: | Entero Therapeutics, Inc. (ENTO) | 03-Apr-23 | Sale | 3,347 | $2.50 | $8,367.50 | (8%) 42.86K to 39.51K | |
05-Jan-23 9:00 AM View: | Entero Therapeutics, Inc. (ENTO) | 03-Jan-23 | Grant | 300,000 | -- | -- | 100% 0 to 300.0K | |
10-Oct-19 9:11 PM View: | Entero Therapeutics, Inc. (ENTO) | 08-Oct-19 | Grant | 200,000 | -- | -- | 100% 0 to 200.0K | |
05-Jan-18 1:09 PM View: | Hepion Pharmaceuticals, Inc. (HEPA) | 03-Jan-18 | Grant | 322,092 | -- | -- | 189% 170.73K to 492.82K | |
07-Jul-17 5:01 PM View: | Hepion Pharmaceuticals, Inc. (HEPA) | 06-Jul-17 | Grant | 141,061 | -- | -- | 475% 29.67K to 170.73K | |
15-Feb-17 3:48 PM View: | Probility Media Corp (PBYA) | 08-Nov-16 | Grant | 75,000 | $0.79 | $59,250.00 | 56% 135.0K to 210.0K | (57%) |
31-Oct-16 5:39 PM View: | Hepion Pharmaceuticals, Inc. (HEPA) | 27-Oct-16 | Option Exercise | 16,666 | $1.50 | $24,999.00 | 128% 13.0K to 29.67K | |
18-Feb-16 11:10 AM View: | Hepion Pharmaceuticals, Inc. (HEPA) | 18-Feb-16 | Market Purchase | 10,000 | $1.00 | $10,000.00 | 333% 3.0K to 13.0K | (100%) |
01-Dec-15 4:05 PM View: | Hepion Pharmaceuticals, Inc. (HEPA) | 30-Nov-15 | Market Purchase | 500 | $2.15 | $1,075.00 | 20% 2.5K to 3.0K | (100%) |
24-Nov-15 4:15 PM View: | Hepion Pharmaceuticals, Inc. (HEPA) | 23-Nov-15 | Market Purchase | 2,500 | $1.64 | $4,100.00 | 100% 0 to 2.5K | (100%) |
05-Sep-14 11:41 AM View: | Cortex Pharmaceuticals Inc. (CORX) | 03-Sep-14 | Grant | 2,000,000 | -- | -- | 100% 0 to 2.0M | |
17-Jan-14 4:40 PM View: | HepaLife Technologies Inc. (ALQA) | 09-Jan-14 | Grant | 17,688 | -- | -- | 84% 21.08K to 38.77K | |
17-Jan-14 4:40 PM View: | HepaLife Technologies Inc. (ALQA) | 09-Jan-14 | Payment of Exercise | 7,104 | $8.18 | $58,110.70 | (18%) 38.77K to 31.66K | 71% |
23-Dec-13 6:00 PM View: | HepaLife Technologies Inc. (ALQA) | 27-Nov-13 | Grant | 35,377 | -- | -- | 100% 0 to 35.38K | |
23-Dec-13 6:00 PM View: | HepaLife Technologies Inc. (ALQA) | 27-Nov-13 | Payment of Exercise | 14,299 | $4.46 | $63,773.50 | (40%) 35.38K to 21.08K |